Literature DB >> 17052065

Fatal delayed transfusion reaction in a sickle cell anemia patient with Serratia marcescens sepsis.

Desiree Seeyave1, Ninad Desai, Scott Miller, Sreedhar P Rao, Steve Piecuch.   

Abstract

Patients with sickle cell anemia may require repeated red cell transfusion, putting them at risk for minor blood group alloimmunization and the development of delayed hemolytic transfusion reactions. Although Streptococcus pneumoniae is the most common cause of life-threatening infection in patients with sickle cell anemia, those who have been recently hospitalized are at risk for infection with resistant hospital-associated organisms, and blood transfusion may put the patient at risk of infection with transfusion-associated organisms such as Serratia marcescens and Yersinic enterocolitica. We recently cared for an adolescent with sickle cell anemia who presented to the emergency department with a severe, delayed hemolytic transfusion reaction and Serratia marcescens infection. The patient had been discharged from the hospital five days previously, and had been transfused and treated with antibiotics while hospitalized. In addition to demonstrating the potential severity of delayed hemolytic transfusion reactions, our case illustrates the importance of providing relatively broad-spectrum antibiotic coverage to patients with sickle cell anemia and possible infection who have recently been hospitalized.

Entities:  

Mesh:

Year:  2006        PMID: 17052065      PMCID: PMC2569743     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  10 in total

1.  New Views of Sickle Cell Disease Pathophysiology and Treatment.

Authors:  Wendell F. Rosse; Mohandas Narla; Lawrence D. Petz; Martin H. Steinberg
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2000

2.  Hyperhemolytic transfusion reaction in sickle cell disease.

Authors:  N Win; H Doughty; P Telfer; B J Wild; T C Pearson
Journal:  Transfusion       Date:  2001-03       Impact factor: 3.157

Review 3.  Antimicrobial therapy for patients with severe sepsis and septic shock: an evidence-based review.

Authors:  Pierre-Yves Bochud; Marc Bonten; Oscar Marchetti; Thierry Calandra
Journal:  Crit Care Med       Date:  2004-11       Impact factor: 7.598

4.  Significance of fever in Jamaican patients with homozygous sickle cell disease.

Authors:  K J Wierenga; I R Hambleton; R M Wilson; H Alexander; B E Serjeant; G R Serjeant
Journal:  Arch Dis Child       Date:  2001-02       Impact factor: 3.791

5.  Transfusion reaction. An immunologic hazard of blood transfusion.

Authors:  A A Pineda; H F Taswell; S M Brzica
Journal:  Transfusion       Date:  1978 Jan-Feb       Impact factor: 3.157

6.  The sickle cell hemolytic transfusion reaction syndrome.

Authors:  L D Petz; L Calhoun; I A Shulman; C Johnson; R M Herron
Journal:  Transfusion       Date:  1997-04       Impact factor: 3.157

7.  Fatal hemolysis induced by ceftriaxone in a child with sickle cell anemia.

Authors:  J C Bernini; M M Mustafa; L J Sutor; G R Buchanan
Journal:  J Pediatr       Date:  1995-05       Impact factor: 4.406

8.  Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.

Authors:  Julie-An M Talano; Cheryl A Hillery; Jerome L Gottschall; Diane M Baylerian; J Paul Scott
Journal:  Pediatrics       Date:  2003-06       Impact factor: 7.124

Review 9.  Red cell antigens as functional molecules and obstacles to transfusion.

Authors:  George Garratty; Marilyn J Telen; Lawrence D Petz
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2002

10.  Septicaemia in sickle cell anaemia patients: the Ibadan experience.

Authors:  Y A Aken'ova; R A Bakare; M A Okunade
Journal:  Cent Afr J Med       Date:  1998-04
  10 in total
  4 in total

Review 1.  Medical and economic implications of strategies to prevent alloimmunization in sickle cell disease.

Authors:  Eric A Gehrie; Paul M Ness; Evan M Bloch; Seema Kacker; Aaron A R Tobian
Journal:  Transfusion       Date:  2017-06-26       Impact factor: 3.157

Review 2.  Serratia infections: from military experiments to current practice.

Authors:  Steven D Mahlen
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

Review 3.  Delayed hemolytic transfusion reaction in sickle cell disease.

Authors:  Leslie P Scheunemann; Kenneth I Ataga
Journal:  Am J Med Sci       Date:  2010-03       Impact factor: 2.378

4.  Recent independent emergence of multiple multidrug-resistant Serratia marcescens clones within the United Kingdom and Ireland.

Authors:  Danesh Moradigaravand; Christine J Boinett; Veronique Martin; Sharon J Peacock; Julian Parkhill
Journal:  Genome Res       Date:  2016-07-18       Impact factor: 9.043

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.